The prevalence of premonitory symptoms in paediatric migraine: A questionnaire study in 103 children and adolescents

Cephalalgia

Volumn 29, Issue 11, 2009, Pages 1197-1201

  Cuvellier, J C ^a,b   Mars, A ^b   Vallee L ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

Author keywords

Children; Migraine; Premonitory symptoms

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PRESCHOOL CHILD; PREVALENCE; QUESTIONNAIRE; SCHOOL CHILD; SYMPTOMATOLOGY;

EID: 70349694344     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2009.01854.x     Document Type: Article

References (19)

1. Abu-Arefeh I, Russell G. Prevalence of headache and migraine in schoolchildren. BMJ 1994 309 : 765 769.
2. Mortimer MJ, Kay J, Jaron A. Epidemiology of headache and childhood migraine in an urban general practice using ad hoc, Vahlquist and IHS criteria. Dev Med Child Neurol 1992 34 : 1095 1101.
3. Headache Classification Committee. The international classification of headache disorders, cranial neuralgia and facial pain, 2nd edn. Cephalalgia 2004 24 (Suppl. 1 1 160.
4. Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 1992 12 : 221 228.
5. Amery WK, Waelkens J, Vandenbergh V. Migraine warnings. Headache 1986 26 : 60 6.
6. Kelman L. The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs. Headache 2004 44 : 865 872. (Pubitemid 39362310)
7. Santoro G, Bernasconi F, Sessa F, Venco A. Premonitory symptoms in migraine without aura: a clinical investigation. Funct Neurol 1990 5 : 339 344.
8. Schoonman GG, Terwindt GM, Van Dijk JG, Ferrari MD. The prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients. Cephalalgia 2006 26 : 1209 1213.
9. Schoonman GG, Evers DJ, van Dijk JG, Ferrari MD. Sensitivity and predictive value of trigger factors and premonitory symptoms in migraine. Cephalalgia 2003 23 : 596.
10. Giffin NJ, Ruggiero L, Lipton RB, Silberstein SD, Tvedskov JF, Olesen J et al. Premonitory symptoms in migraine: an electronic diary study. Neurology 2003 60 : 935 940.
11. Weiller C, May A, Limmroth V, Jüptner M, Kaube H, Schayck RV et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995 1 : 658 660.
12. Bahra A, Matharu MS, Buchel C, Frackowiak RSJ, Goadsby PJ. Brainstem activation specific to migraine headache. Lancet 2001 357 : 1016 1017.
13. Afridi SK, Kaube H, Goadsby PJ. Glyceryl trinitrate triggers premonitory symptoms in migraine. Pain 2004 110 : 675 680.
14. Del Zompo M, Cherchi A, Palmas MA, Ponti M, Bocchetta A, Gessa GL, Piccardi MP. Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology 1998 51 : 781 786.
15. Rossi P, Ambrosini A, Buzzi MG. Prodromes and predictors of migraine attack. Funct Neurol 2005 20 : 185 191.
16. Luciani R, Carter D, Mannix L, Hemphill M, Diamond M, Cady R. Prevention of migraine during prodrome with naratriptan. Cephalalgia 2000 20 : 122 126.
17. Matta SGF. Metoclopramide in the treatment of migraine. Practitioner 1974 212 : 887 890.
18. Waelkens J. Domperidone in the prevention of complete classical migraine. BMJ 1982 284 : 944.
19. Waelkens J. Dopamine blockade with domperidone: bridge between prophylactic and abortive treatment of migraine? A dose-finding study. Cephalalgia 1984 4 : 85 90.